From July 1, 2022 to September 30, 2022, the company has repurchased 1,886,026 shares, representing 0.47% for CNY 45.69 million. With this, the company has completed the repurchase of 2,580,826 shares, representing 0.65% for CNY 77.81 million under the buyback announced on February 14, 2022.
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
18.36 CNY | +1.21% |
|
-0.43% | -16.47% |
Jun. 13 | Amoy Diagnostics Gets Certificate to Register PCR Analyzer | MT |
May. 24 | Amoy Diagnostics Co., Ltd. Announces Cash Dividend on A Shares for the Year 2023, Payable on 30 May 2024 | CI |
![Consensus](/images/consensus_flch.gif)
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-16.47% | 998M | |
-11.68% | 11.22B | |
-10.38% | 7.58B | |
+27.58% | 5.48B | |
+1.44% | 5.38B | |
-17.38% | 3.77B | |
+8.12% | 2.6B | |
-64.90% | 2.35B | |
+26.75% | 2.2B | |
-12.53% | 1.7B |
- Stock Market
- Equities
- 300685 Stock
- News Amoy Diagnostics Co., Ltd.
- Tranche Update on Amoy Diagnostics Co., Ltd.'s Equity Buyback Plan announced on February 14, 2022.